bahria university Health sciences campus karachi
Karachi, Sindh, 75300, Pakistan
Location status: Recruiting
NCT Number: NCT06842108
Diabetes mellitus being metabolic disorder, chronic in nature, is characterized by high levels of glucose in our blood, which often lead to organ dysfunction. Approximately 10.5 % of adult (20-79 years) have diabetes according to international Diabetes federation. Cardiorespiratory fitness (CRF) is the capability of our cardiopulmonary system to make oxygen available to our skeletal muscles during physical activities for prolonged time, and is known to be decreased with diabetes. Hemodynamic parameters are correlated with various cardiovascular disorders but little evidence of hemodynamic changes in diabetes patients is present and more studies must be done. This study aims to establish the link between hemodynamic changes and cardiopulmonary fitness in T2DM patients, which could inform clinical practices and interventions to improve management, reduce cardiovascular risks, and enhance the quality of life for these patients.
Interested in participating?
Request Info30 year–50 year
All sexes
Observational
Karachi, Sindh, 75300, Pakistan
Location status: Recruiting
Diabetes mellitus being metabolic disorder, chronic in nature, is characterized by high levels of glucose in our blood, which often lead to organ dysfunction.[1] Diabetes statistics highlight the increasing worldwide impact on individuals, families and nations. Approximately 10.5 % of adult (20-79 years) have diabetes according to international Diabetes federation. [2] Cardiorespiratory fitness (CRF) is the capability of our cardiopulmonary system to make oxygen available to our skeletal muscles during physical activities for prolonged time. [3] Diabetes and cardiorespiratory fitness are inter related. According to a 2023 studies on Cardiorespiratory fitness in individuals with T2DM, it was found that T2DM was associated with decreased cardiorespiratory fitness.
Hemodynamic characteristics have been linked to diseases like stroke,, hypertension, and vascular stenosis. Only a few modest studies have investigated the relationship between hemodynamics and diabetes mellitus (DM). The evidence for a link between hemodynamic alterations and CRF in type 2 diabetic individuals needs to be demonstrated. The study aimed to identify the relationship between hemodynamic changes and CRF in type 2 diabetic patients; the findings will help us form inform clinical practices and intervention strategies, ultimately leading to better T2DM management, lowering the risk of cardiovascular complications, and improving T2DM patients' quality of life and longevity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
STEP 1:
Patient Preparation
STEP 2:
Consent and history:
STEP 3:
Start of ETT:
STEP 4:
Parameters Recorded During ETT:
STEP 5:
Cardiopulmonary Fitness Assessment VO2 Max
Time frame: Immediately after performing test
it will be assessed through ΔHeart Rate and HRR1
Time frame: immediately after performing test
it will be measured from VO2 max.
Contact information is provided by the study sponsor or research team.
Bahria University
Other
Acronym: diabetes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06638099
Diabetes, Diabetes Mellitus
El Centro, California, United States
View Trial DetailsNCT03132181
Diabetes Mellitus, Diabetes Mellitus Type 2 (T2DM)
Aachen, North Rhine-Westphalia, Germany
View Trial DetailsNCT06957093
Artificial Intelligence (AI), Diabetes Mellitus
Changchun, Jilin, China
View Trial DetailsNCT06724913
Diabetes Mellitus, Diabetes Mellitus Type 2 (T2DM)
Moscow, Russia
View Trial Details